VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
-14.02%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$18.4B
AUM Growth
–
Cap. Flow
+$18.4B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
28.05%
Holding
651
New
651
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
GG
Goldcorp Inc
GG
|
$919M |
| 2 |
Newmont
NEM
|
$716M |
| 3 |
B
Barrick Mining Corporation
B
|
$624M |
| 4 |
Schlumberger
SLB
|
$577M |
| 5 |
GOLD
Randgold Resources Ltd
GOLD
|
$421M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Materials | 45.25% |
| 2 | Energy | 26.07% |
| 3 | Industrials | 5.85% |
| 4 | Consumer Staples | 4.48% |
| 5 | Healthcare | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARMH
151
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $11.6M | 0.06% |
+320,883
| New | +$11.6M |
|
152
Bristol-Myers Squibb
BMY
$95B
| $11.6M | 0.06% |
+258,445
| New | +$11.6M |
|
153
Franklin Resources
BEN
$13.4B
| $11.5M | 0.06% |
+252,888
| New | +$11.5M |
|
|
JOY
154
DELISTED
Joy Global Inc
JOY
| $11.4M | 0.06% |
+234,845
| New | +$11.4M |
|
155
Green Plains
GPRE
$731M
| $11.3M | 0.06% |
+851,700
| New | +$11.3M |
|
156
Vista Gold
VGZ
$168M
| $11.3M | 0.06% |
+11,610,354
| New | +$11.3M |
|
157
Applied Materials
AMAT
$126B
| $11.1M | 0.06% |
+746,989
| New | +$11.1M |
|
158
Oracle
ORCL
$626B
| $11.1M | 0.06% |
+362,038
| New | +$11.1M |
|
159
Vulcan Materials
VMC
$38.6B
| $11M | 0.06% |
+227,559
| New | +$11M |
|
160
Analog Devices
ADI
$121B
| $11M | 0.06% |
+243,526
| New | +$11M |
|
|
QGENF
161
DELISTED
QIAGEN NV
QGENF
| $11M | 0.06% |
+550,979
| New | +$11M |
|
|
PCYC
162
DELISTED
PHARMACYCLICS INC
PCYC
| $10.9M | 0.06% |
+136,727
| New | +$10.9M |
|
163
Teva Pharmaceuticals
TEVA
$21.2B
| $10.9M | 0.06% |
+277,180
| New | +$10.9M |
|
164
Paramount Gold Nevada
PZG
$74.3M
| $10.7M | 0.06% |
+9,026,688
| New | +$10.7M |
|
165
AbbVie
ABBV
$376B
| $10.5M | 0.06% |
+253,266
| New | +$10.5M |
|
166
Abbott
ABT
$231B
| $10.4M | 0.06% |
+297,262
| New | +$10.4M |
|
167
Eli Lilly
LLY
$666B
| $10.3M | 0.06% |
+209,197
| New | +$10.3M |
|
168
AstraZeneca
AZN
$254B
| $10.1M | 0.05% |
+424,960
| New | +$10.1M |
|
169
Novo Nordisk
NVO
$249B
| $10M | 0.05% |
+645,740
| New | +$10M |
|
170
Bausch Health
BHC
$2.67B
| $9.62M | 0.05% |
+111,702
| New | +$9.62M |
|
|
BTU
171
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $9.32M | 0.05% |
+42,433
| New | +$9.32M |
|
|
AGN
172
DELISTED
ALLERGAN INC
AGN
| $9.1M | 0.05% |
+108,063
| New | +$9.1M |
|
|
CRR
173
DELISTED
Carbo Ceramics Inc.
CRR
| $9.05M | 0.05% |
+134,186
| New | +$9.05M |
|
|
CQB
174
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $8.84M | 0.05% |
+809,115
| New | +$8.84M |
|
|
ALTR
175
DELISTED
ALTERA CORP
ALTR
| $8.51M | 0.05% |
+258,016
| New | +$8.51M |
|